The bariatric surgery devices market is anticipated to have a significant CAGR of 4.5% during the period of 2022-2032.
The bariatric surgery devices market is predicted to grow from US$ 2.1 Billion in 2022 to US$ 3 Billion in 2032. Previously, the market was thriving at a higher CAGR of 5.2% (2015-2021), resulting in market size of US$ 2 Billion in 2021.
Obesity is a chronic condition that has become increasingly prevalent globally. According to the World Health Organization, worldwide obesity rates have tripled since 1975, with over 1.9 billion adults being overweight, and 650 million being classified as obese. Bariatric surgery is an effective treatment for morbid obesity that involves the use of surgical devices designed to modify the stomach’s size and shape, restrict food intake, and reduce absorption. This report will provide an overview of the different types of bariatric surgery devices currently available on the market, their benefits, and potential risks.
Get Sample Copy of this Report @ https://www.persistencemarketresearch.com/samples/33102
The COVID-19 pandemic has severely harmed the global bariatric surgical devices market. In the early months of the pandemic, the spread of COVID-19 infection caused a significant drop in sales of bariatric surgery devices in the medical equipment industry. Moreover, during the pandemic, all elective procedures were postponed or cancelled in order to maximize hospital capacity use for COVID-19 patients.
Company Profiles:
- Ethicon
- Medtronic
- Intuitive Surgical
- Apollo Endosurgery
- ReShape Lifesciences
- Aspire Bariatrics
- Mediflex Surgical Products
- Spatz FGIA
- Cousin Biotech
Request for Methodology @ https://www.persistencemarketresearch.com/methodology/33102
Bariatric surgery devices market trends like established and emerging medical surgeons are improving and qualifying their surgical expertise as bariatric surgery becomes increasingly popular. As a result, demand for bariatric surgical devices is increasing.
The post-surgical consequences are creating a huge obstacle in living with bariatric surgery, hampering the adoption of bariatric surgery devices. North America is anticipated to be the leading region in the bariatric surgery devices market.
RECENT DEVELOPMENT:
Partnerships, Collaborations, and Agreements:
- Standard Bariatrics, Inc of Cincinnati, invented the Titan SGS™, a first-of-its-kind device that provides surgeons undergoing sleeve gastrectomy, the most frequent bariatric surgery for obesity, with the industry’s longest continuous staple cutline of 23 centimeters.
- Apollo received 510(k) clearance from the US Food and Drug Administration (FDA) in 2019. (k). This was done in regards to the use of polypropylene suture in OverStitch Endoscopic Suturing devices. The company’s gross margins increased dramatically, and its reliance on a third party significantly decreased.
- Intuitive Surgical’s MEE Commercial Centre opened in Freiburg (Breisgau). The company’s global presence has improved. In February 2020, Medtronic purchased Digital Surgery, a well-known player in the field of surgical artificial intelligence, data, and analytics.
Key Takeaways
- The bariatric surgery devices market is predicted to develop at a CAGR of 4.5%, with a market share of US$ 3 Billion through 2032.
- In the United States, the bariatric surgery devices market is estimated to reach US$ 1 Billion, with a CAGR of 4.3% through 2032.
- The bariatric surgery devices market in China is expected to have a prodigious CAGR of 4.2% through 2032, with the expected market share of US$ 208 Million.
- The bariatric surgery devices market in Japan is expected to reach US$ 182 Million, with a steady CAGR of 4% through 2032.
- The bariatric surgery devices market in the UK is expected to have a market share of US$ 119 Million, with a CAGR of 3.6% through 2032.
- The bariatric surgery devices market’s minimally invasive surgical devices segment from the type category is predicted to develop at a CAGR of 3.5% through 2032.
- The bariatric surgery devices market’s sleeve gastrectomy segment from the procedure category is predicted to develop at a CAGR of 3.7% through 2032.
If You Want To Know The Business Opportunity/Market Value, Purchase The Premium Insight @ https://www.persistencemarketresearch.com/checkout/33102
Related Reports:
Global Biological Drugs Market
Obesity Surgery Devices Market
Umbilical Cord Blood Banking Market
About Us:
Persistence Market Research is a U.S.-based full-service market intelligence firm specializing in syndicated research, custom research, and consulting services. Persistence Market Research boasts market research expertise across the Healthcare, Chemicals and Materials, Technology and Media, Energy and Mining, Food and Beverages, Semiconductor and Electronics, Consumer Goods, and Shipping and Transportation industries. The company draws from its multi-disciplinary capabilities and high-pedigree team of analysts to share data that precisely corresponds to clients’ business needs.
Contact Us:
Persistence Market Research
Address – 305 Broadway, 7th Floor, New York City, NY 10007 United States
U.S. Ph. – +1-646-568-7751
USA-Canada Toll-free – +1 800-961-0353
Sales – sales@persistencemarketresearch.com
Website – https://www.persistencemarketresearch.com